Amino-modified Nucleosides
(2R,3S,5R)-5-(6-Aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol
Quick view. A stereospecified 6-aminopurin-7-yl 2'-deoxyribonucleoside for structure-specific nucleoside research and synthesis. CAS 148171-35-1. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
(2R,3S,5R)-5-(6-Aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol is classified as amino-modified nucleosides (Formula C10H13N5O3; molecular weight 251.24).
(2R,3S,5R)-5-(6-Aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol — Reference material or synthetic intermediate in structure-specific purine nucleoside research.
For (2R,3S,5R)-5-(6-Aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol, functional handles may require orthogonal protection, pH control and rapid purification to avoid hydrolysis, oxidation or cross-reaction.
Names and search terms
Confirmed or normalized name variants
- 6-Amino-9-[2-deoxy-beta-D-ribofuranosyl]-9H-purine
Useful catalog search terms
- CAS 148171-35-1
- PubChem CID 15216868
Physicochemical data
| PubChem CID | 15216868 |
|---|---|
| InChIKey | VGSMHXAPKCTFOZ-RRKCRQDMSA-N |
| IUPAC name | (2R,3S,5R)-5-(6-aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol |
| SMILES | C1[C@@H]([C@H](O[C@H]1N2C=NC3=NC=NC(=C32)N)CO)O |
| Glycosidic linkage | 6-Aminopurin-7-yl |
| InChI | InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)14-4-15(8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Product-specific evaluation notes
Potential advantages
- Reactive handles make the product adaptable across dye-labeling, surface-coupling and ligand-conjugation workflows.
Method limitations
- Functional handles may require orthogonal protection, pH control and rapid purification to avoid hydrolysis, oxidation or cross-reaction.
These points describe (2R,3S,5R)-5-(6-Aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
3'-NH₂-ddA
Amino-modified Nucleosides · CAS: 7403-25-0
BX-MN-00073'-NH₂-ddC
Amino-modified Nucleosides · CAS: 84472-90-2
BX-MN-00083'-NH₂-ddG
Amino-modified Nucleosides · CAS: 66323-49-7
BX-MN-01762-Aminoadenosine
Amino-modified Nucleosides · CAS: 2096-10-8
BX-AMN-01343'-beta-Azido-2',3'-dideoxyuridine
Amino-modified Nucleosides · CAS: 101039-96-7
BX-AMN-00072-Amino-2',3'-dideoxyadenosine
Amino-modified Nucleosides · CAS: 107550-73-2
Frequently asked questions
Can the package size for (2R,3S,5R)-5-(6-Aminopurin-7-yl)-2-(hydroxymethyl)oxolan-3-ol be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-AMN-0028 and CAS 148171-35-1, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Amino-modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.